drugset / Trial / NCT00199420
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
RandomizedParallel-groupDouble-blindTreatment
Summary
To establish the efficacy of 10, 20 and 40 mg/d dose of istradefylline for reducing the percentage of OFF time in patients with advanced Parkinson's disease (PD) treated with levodopa.
Timeline
- Start
- 2004-07
- Primary completion
- 2005-11
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Istradefylline | Small molecule | 10 mg | Oral |
| Subject | Istradefylline | Small molecule | 20 mg | Oral |
| Subject | Istradefylline | Small molecule | 40 mg | Oral |